NVIDIA
NVDA
Meta Platforms
META
Tesla
TSLA
Alphabet-A
GOOGL
Alphabet-C
GOOG
US Stock MarketDetailed Quotes
SRNE Sorrento Therapeutics
- 0.001
- 0.0000.00%
15min DelayTrading Dec 23 11:51 ET
441.02KMarket Cap0.00P/E (TTM)
0.001High0.000Low245.65KVolume0.001Open0.001Pre Close194.88Turnover0.05%Turnover Ratio0.00P/E (Static)551.28MShares0.13952wk High0.00P/B436.66KFloat Cap0.00052wk Low--Dividend TTM545.82MShs Float302.685Historical High--Div YieldTTM87.50%Amplitude0.000Historical Low0.000Avg Price1Lot Size
Sorrento Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 31.28%-55.66M | 40.67%-49.46M | -4.27%-293.86M | 5.27%-68.34M | 26.40%-61.17M | -3.15%-80.99M | -73.46%-83.36M | -76.65%-281.82M | -76.51%-72.14M | -95.14%-83.11M |
| Net income from continuing operations | 50.59%-108.44M | -281.42%-154.63M | -34.63%-577.76M | -56.78%-227.11M | 24.48%-90.63M | -31.66%-219.48M | -1,776.59%-40.54M | -36.49%-429.14M | -98.10%-144.86M | -37.75%-120M |
| Operating gains losses | -98.18%1.8M | 121.76%15.37M | 207.31%68.02M | 79.46%57.98M | -218.47%-17.91M | 52.13%98.59M | 21.60%-70.64M | -56.76%22.13M | 4,872.38%32.31M | 865.45%15.12M |
| Depreciation and amortization | 11.03%3.59M | 9.85%3.62M | 6.28%13.25M | 17.28%3.35M | -5.33%3.36M | 3.12%3.24M | 13.02%3.3M | 13.22%12.46M | 28.96%2.86M | 13.07%3.55M |
| Deferred tax | -574.27%-11.85M | 958.38%11.49M | 94.89%-1.84M | 96.62%-1.15M | 98.80%-11K | -152.08%-1.76M | 595.89%1.09M | -1,590.68%-35.93M | -24,968.38%-34.09M | ---918K |
| Other non cash items | 113.49%10.31M | 52.97%11.13M | -204.68%-64.12M | -89.13%4.39M | -95.48%611K | -5,119.32%-76.39M | 25.00%7.28M | 2.79%61.25M | 513.27%40.38M | -64.84%13.53M |
| Change In working capital | 485.81%33.45M | 761.67%30.64M | 2,591.97%69.55M | 406.98%43.57M | 260.71%24.91M | 271.37%5.71M | -162.19%-4.63M | -173.47%-2.79M | 39.43%8.59M | -212.33%-15.5M |
| -Change in receivables | -272.81%-6.21M | 65.78%-2.05M | -92.09%-5.68M | 87.70%-278K | -511.61%-3.01M | 673.96%3.59M | -644.96%-5.98M | -181.35%-2.96M | -206.23%-2.26M | 175.62%732K |
| -Change in inventory | 90.77%-498K | 77.71%-1.33M | -51.53%-9.51M | -490.58%-5.01M | 350.78%6.88M | -97.29%-5.4M | -11,823.53%-5.98M | -509.66%-6.28M | ---849K | ---2.74M |
| -Change in prepaid assets | -48.90%3.03M | 107.99%131K | 218.46%6.8M | 142.04%2.15M | 128.92%374K | 2,317.23%5.92M | -276.53%-1.64M | -216.89%-5.74M | -1,672.92%-5.11M | -143.45%-1.29M |
| -Change in payables and accrued expense | 2,055.97%40.79M | 222.34%33.85M | 1,040.71%191.16M | 1,616.65%156.84M | 4.80%21.93M | 872.24%1.89M | 63.63%10.5M | 20,847.50%16.76M | -303.72%-10.34M | 459.39%20.93M |
| -Change in other working capital | -1,123.75%-3.66M | 102.94%45K | -2,375.88%-113.22M | -1,967.20%-110.68M | -16.83%-715K | -155.27%-299K | -279.58%-1.53M | -173.01%-4.57M | -16,631.25%-5.35M | 46.64%-612K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 31.28%-55.66M | 40.67%-49.46M | -4.27%-293.86M | 5.27%-68.34M | 26.40%-61.17M | -3.15%-80.99M | -73.46%-83.36M | -76.65%-281.82M | -76.51%-72.14M | -95.14%-83.11M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 91.90%-140K | 112.32%1.68M | -135.72%-28.52M | -128.30%-5.03M | -249.96%-8.09M | -102.20%-1.73M | -581.16%-13.66M | 300.00%79.85M | 80.68%-2.21M | 121.39%5.4M |
| Net PPE purchase and sale | 94.82%-140K | 96.68%-86K | -53.95%-13.66M | -104.80%-4.52M | -226.38%-3.84M | 22.56%-2.71M | -30.04%-2.59M | -35.89%-8.87M | 17.82%-2.21M | 59.06%-1.18M |
| Net business purchase and sale | --0 | --0 | 58.78%-14.86M | 21.54%-510K | 80.97%-4.26M | 107.51%977K | -92,158.33%-11.07M | -7.95%-36.05M | 97.91%-650K | -69,809.38%-22.37M |
| Net investment purchase and sale | --0 | --1.77M | --0 | --0 | --0 | --0 | --0 | --124.77M | --654K | --28.94M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 91.90%-140K | 112.32%1.68M | -135.72%-28.52M | -128.30%-5.03M | -249.96%-8.09M | -102.20%-1.73M | -581.16%-13.66M | 300.00%79.85M | 80.68%-2.21M | 121.39%5.4M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 112.62%88.81M | -64.70%61.2M | 71.90%311.72M | -64.60%25.08M | 78.48%71.5M | 19.15%41.77M | 390.34%173.37M | 4.07%181.33M | 712.10%70.86M | -66.01%40.06M |
| Net issuance payments of debt | 245.34%91.64M | 334.13%38.23M | -156.84%-92.24M | -2,278.62%-38.02M | 100.73%23K | -269.35%-63.05M | 150.46%8.81M | 80.79%-35.91M | 102.82%1.75M | -224.84%-3.14M |
| Net common stock issuance | -102.10%-2.19M | -86.03%22.97M | 99.35%402.33M | -6.94%62.3M | 70.47%71.46M | 105.21%104.15M | 289.57%164.43M | -23.22%201.83M | 34.28%66.95M | -34.26%41.92M |
| Proceeds from stock option exercised by employees | 10.70%745K | --0 | -92.23%1.2M | -82.77%373K | -98.44%20K | -51.13%673K | -98.75%132K | -84.32%15.42M | 300.18%2.17M | -97.67%1.28M |
| Net other financing activities | ---- | ---- | --426K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 112.62%88.81M | -64.70%61.2M | 71.90%311.72M | -64.60%25.08M | 78.48%71.5M | 19.15%41.77M | 390.34%173.37M | 4.07%181.33M | 712.10%70.86M | -66.01%40.06M |
| Net cash flow | ||||||||||
| Beginning cash position | -66.35%37.66M | -35.54%23.63M | -35.06%36.67M | 77.89%70.69M | -8.99%70.35M | 168.50%111.91M | -35.06%36.67M | -30.09%56.46M | -66.94%39.74M | 11.39%77.29M |
| Current changes in cash | 180.63%33.01M | -82.42%13.42M | 48.37%-10.66M | -1,285.71%-48.29M | 105.94%2.24M | -216.30%-40.95M | 619.14%76.35M | 18.15%-20.64M | 94.54%-3.49M | -175.26%-37.66M |
| Effect of exchange rate changes | -49.35%-920K | 154.35%600K | -381.61%-2.37M | 198.80%1.24M | -1,994.00%-1.89M | -250.98%-616K | -1,280.00%-1.1M | -7.87%843K | 182.31%415K | -86.74%100K |
| End cash Position | -0.85%69.75M | -66.35%37.66M | -35.54%23.63M | -35.54%23.63M | 77.89%70.69M | -8.99%70.35M | 168.50%111.91M | -35.06%36.67M | -35.06%36.67M | -66.94%39.74M |
| Free cash flow | 33.33%-55.8M | 42.36%-49.55M | -5.79%-307.51M | 2.00%-72.86M | 22.88%-65.01M | -2.05%-83.69M | -71.73%-85.95M | -75.05%-290.69M | -250.16%-74.35M | -24.34%-84.29M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.